Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Clinical Diagnostic Market, By Test, By Product, By End User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028" report...
-
PERSBERICHT: VOORWETENSCHAP / GEREGLEMENTEERDE INFORMATIE11 april 2023, 22:00 CEST Biocartis benoemt Roger Moody als nieuwe CEO Roger Moody wordt benoemd tot de nieuwe Chief Executive Officer en...
-
PRESS RELEASE: INSIDE INFORMATION/ REGULATED INFORMATION11 April 2023, 22:00 CEST Biocartis appoints Roger Moody as new CEO Roger Moody to be appointed as new Chief Executive Officer and member of...
-
Dublin, April 11, 2023 (GLOBE NEWSWIRE) -- The "Cellular Health Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cellular...
-
PERSBERICHT: GEREGLEMENTEERDE INFORMATIE11 april 2023, 07:01 CEST Oproeping tot de Gewone Algemene Aandeelhoudersvergadering Mechelen, België, 11 april 2023 – Biocartis Group NV (de ‘Vennootschap’...
-
PRESS RELEASE: REGULATED INFORMATION 11 April 2023, 07:01 CEST Invitation to the Annual Shareholders’ Meeting Mechelen, Belgium, 11 April 2023 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’),...
-
PERSBERICHT: GEREGLEMENTEERDE INFORMATIE 11 april 2023, 7:00 CEST Biocartis kondigt publicatie 2022 jaarverslag aan Mechelen, België, 11 april 2023 – Biocartis Group NV (de ‘Vennootschap’ of...
-
PRESS RELEASE: REGULATED INFORMATION 11 April 2023, 07:00 CEST Biocartis Announces Publication of 2022 Annual Report Mechelen, Belgium, 11 April 2023 – Biocartis Group NV (the ‘Company’ or...
-
Wilmington, Delaware, United States, April 07, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – According to research, the global in vitro diagnostics market was worth US$ 70.51 Bn in...
-
Parties add several deliverables to initial R&D collaboration contractOverall potential revenue increased to up to euro 830 thousand ROCKVILLE, Md., April 05, 2023 (GLOBE NEWSWIRE) -- OpGen,...